Exscientia

Exscientia is a company that focuses on the application of artificial intelligence (AI) in the realm of drug discovery. The company's primary goal is to speed up the process of creating life-saving medicines by using AI to automate drug design, thereby reducing the time, cost, and risks associated with the development of new drugs. They collaborate with various biopharmaceutical and healthcare companies to help them discover and design high-quality drug candidates more efficiently.

The company's AI-driven platform is capable of analysing vast amounts of data to find potential drug candidates, then designing and optimizing those molecules for effectiveness and safety. Exscientia's platform can perform these tasks much faster than traditional methods, significantly speeding up the drug discovery process. The company's work has led to the creation of the first AI-designed drug to be used in human trials, demonstrating the potential of AI in drug discovery and design.